St Jude gains strong lead in quarter one as heart rivals suffer dent in profits
This article was originally published in Clinica
Executive Summary
Shares in St Jude Medical hit a 12-month high after its first-quarter results shot ahead of analysts' expectations. Sales during the quarter climbed 13% $887m, bolstered by a strong performance from its major product lines, while favourable currency exchange rate gave an additional boost. Profits rose 6% to $146m, or $0.41 per share.